Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts
Konrad Hoeft, … , Sikander Hayat, Rafael Kramann
Konrad Hoeft, … , Sikander Hayat, Rafael Kramann
Published September 17, 2024
Citation Information: J Clin Invest. 2024;134(18):e170246. https://doi.org/10.1172/JCI170246.
View: Text | PDF
Research Article Cardiology Nephrology Article has an altmetric score of 42

ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts

  • Text
  • PDF
Abstract

Fibrosis represents the uncontrolled replacement of parenchymal tissue with extracellular matrix (ECM) produced by myofibroblasts. While genetic fate-tracing and single-cell RNA-Seq technologies have helped elucidate fibroblast heterogeneity and ontogeny beyond fibroblast to myofibroblast differentiation, newly identified fibroblast populations remain ill defined, with respect to both the molecular cues driving their differentiation and their subsequent role in fibrosis. Using an unbiased approach, we identified the metalloprotease ADAMTS12 as a fibroblast-specific gene that is strongly upregulated during active fibrogenesis in humans and mice. Functional in vivo KO studies in mice confirmed that Adamts12 was critical during fibrogenesis in both heart and kidney. Mechanistically, using a combination of spatial transcriptomics and expression of catalytically active or inactive ADAMTS12, we demonstrated that the active protease of ADAMTS12 shaped ECM composition and cleaved hemicentin 1 (HMCN1) to enable the activation and migration of a distinct injury-responsive fibroblast subset defined by aberrant high JAK/STAT signaling.

Authors

Konrad Hoeft, Lars Koch, Susanne Ziegler, Ling Zhang, Steffen Luetke, Maria C. Tanzer, Debashish Mohanta, David Schumacher, Felix Schreibing, Qingqing Long, Hyojin Kim, Barbara M. Klinkhammer, Carla Schikarski, Sidrah Maryam, Mathijs Baens, Juliane Hermann, Sarah Krieg, Fabian Peisker, Laura De Laporte, Gideon J.L. Schaefer, Sylvia Menzel, Joachim Jankowski, Benjamin D. Humphreys, Adam Wahida, Rebekka K. Schneider, Matthias Versele, Peter Boor, Matthias Mann, Gerhard Sengle, Sikander Hayat, Rafael Kramann

×

Figure 7

HMCN1 is a substrate of ADAMTS12 that facilitates ADAMTS12-induced migration.

Options: View larger image (or click on image) Download as PowerPoint
HMCN1 is a substrate of ADAMTS12 that facilitates ADAMTS12-induced migra...
(A) log2FC of the top up- and downregulated proteins in ECM of WT versus ADAMTS12-KO PDGFRβ+ cells (n = 3 per group). (B) Western blot of lower-weight HMCN1 peptides (56 kDa) in kidneys from WT and Adamts12–/– mice after sham or UUO surgery (Adamts12–/– n = 6, WT n = 7). (C) Quantification of band density via a 2-tailed unpaired t test. (D) Digestion of HMCN1 or control IP lysates with ADAMTS12 or vehicle and subsequent detection of HMCN1 via Western blotting. (E) Digestion of supernatant from HMCN1-expressing RPE cells with vehicle or 2 concentrations of ADAMTS12 (1× = 90 ng, 2× = 180 ng). Detection of HMCN1 by Western blotting. (F) Trajectory maps of the migration of ADAMTS12-KO and active ADAMTS12-overexpressing PDGFRβ+ cells treated with scrambled or HMCN1 siRNA. Quantification of the average speed per field of view (KO/scrambled siRNA n = 136, KO/HMCN1 siRNA n = 112, Act/scrambled siRNA n = 48, Act/HMCN1 siRNA n = 57, PKO scrambled siRNA vs. KO HMCN1 siRNA = 0.69, PAct scrambled siRNA vs. Act HMCN1 siRNA<0.0001, by 2-way ANOVA with Tukey’s post hoc test). ***P < 0.001 and ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 57 X users
On 1 Facebook pages
10 readers on Mendeley
See more details